Statement of Principles concerning asbestosis (Reasonable Hypothesis) (No. 59 of 2021)

The instrument rests on a small number of tightly framed legal and medical concepts. These are stated in the operative provisions and the Schedule. The main concepts to track are as follows, with the source provisions indicated.

• Asbestosis, defined as interstitial fibrosis of the lung caused by deposition of asbestos fibres in the lung parenchyma (s7(2)). The instrument makes clear that the clinical/etiological definition in s7(2) governs, even though asbestosis also appears in ICD‑10‑AM as J61 (s7(3)-(4)). This means that a diagnostic code alone is not the controlling definition; the statutory description is the operative concept.
• Death from asbestosis, which includes death from a terminal event or condition that was contributed to by the person's asbestosis (s7(5)). "Terminal event" is defined in Schedule 1 to include pneumonia, respiratory failure, cardiac arrest, circulatory failure and cessation of brain function. The instrument therefore ties mortality causation to both the underlying asbestosis diagnosis and its contribution to proximate causes of death.
• Reasonable hypothesis. The instrument is determined under subsection 196B(2) of the VEA and repeatedly frames the listed factors as those that must at minimum exist "before it can be said that a reasonable hypothesis has been raised" connecting asbestosis to relevant service (s9). The instrument therefore sets threshold factual predicates for the statutory causation test used in the VEA/MRCA claims context.
• Exposure factors stated with quantitative thresholds. Section 9 establishes cumulative exposure thresholds and latency/timing rules:
  • Enclosed-space exposure while asbestos-containing material was being worked on: cumulative period at least 1,000 hours before clinical onset, with first inhalation at least 5 years before clinical onset (s9(1)(a)-(b)).
  • Open-environment exposure under otherwise parallel conditions: cumulative period at least 3,000 hours before clinical onset, with first inhalation at least 5 years before clinical onset (s9(2)(a)-(b)).
  • Exposure causing clinical worsening: cumulative period at least 1,000 hours before clinical worsening and within 2 years before clinical worsening (s9(3)(a)-(b)).
  • Non-exposure factor: inability to obtain appropriate clinical management for asbestosis (s9(4)).
• Relationship to relevant service. Section 10 requires that any factor relied on under s9 be related to the person's relevant service. It also limits the operation of s9(3)-(4) to material contribution or aggravation where the person's asbestosis was suffered or contracted before or during (but did not arise out of) the person's relevant service (s10(2)). In short, the instrument distinguishes primary causation from material contribution/aggravation and links specific factors accordingly.
• Interaction with other Statements of Principles. Section 11 provides that where a factor in this instrument refers to an injury or disease for which a separate Statement of Principles exists, the factors in that other Statement apply according to their terms as in force from time to time. This creates an inter‑Statement cross-reference mechanism.

Supporting items in the Schedule include the definitions of "relevant service" which enumerates the categories of service under the VEA and MRCA (Schedule 1), and the definition of "terminal event" which identifies proximate causes of death that may be contributed to by asbestosis (Schedule 1). The RMA’s view that there is "sound medical‑scientific evidence" is recorded in s8, which is the instrument’s statement of evidential basis rather than a procedural rule.

These concepts structure how a claim alleging asbestosis will be evaluated under the VEA/MRCA insofar as the Statements of Principles are the statutory vehicle that sets the medical causation predicates used in the statutory "reasonable hypothesis" test.

This Statement of Principles affects a defined set of actors in the statutory veterans' compensation and rehabilitation ecosystem. The instrument itself identifies who it applies to and who must be engaged in decision-making.

Primary persons affected

• Veterans, former members and dependants making claims. The instrument applies to a claim to which section 120A of the VEA or section 338 of the MRCA applies (s5). The Schedule defines "relevant service" to include operational service, peacekeeping service, hazardous service and British nuclear test defence service under the VEA, plus warlike and non-warlike service under the MRCA (Schedule 1). Therefore any person asserting an entitlement under the VEA or MRCA based on asbestosis or death from asbestosis is directly affected because the instrument sets the causation predicates that must be met to raise a reasonable hypothesis connecting the disease to service.
• Dependants asserting death claims. Because the instrument expressly includes death from a terminal event or condition contributed to by asbestosis (s7(5)), persons asserting entitlement based on a veteran’s death will be affected. The Schedule’s list of terminal events provides the proximate causes that may be pleaded as contributed-to by asbestosis.

Decision-makers and medical assessors

• The Repatriation Medical Authority. The RMA is the body that determined the Statement of Principles under subsection 196B(2) of the VEA (s3). The instrument records the RMA’s view about the existence of sound medical‑scientific evidence (s8) and provides the factors the RMA has determined are the relevant minimum predicates.
• Administrators under the VEA and MRCA. The instrument binds the administrative machinery that applies the VEA and MRCA causation framework because the Statement applies to claims under the cited sections (s5). Agency decision-makers will use the factors in s9, and the related rules in s10 and s11, when assessing whether a reasonable hypothesis has been raised.

Medical practitioners and experts

• Treating clinicians and forensic medical experts. The instrument’s requirements make clinical diagnosis (the presence of interstitial fibrosis caused by asbestos fibre deposition) and timing of clinical onset/worsening central issues (s7(2); s9). Medical reports, including clinical interpretation of imaging, lung function, and disease progression, will be necessary components of inquiries, although the instrument does not prescribe evidentiary mechanics.

Employers, record-keepers and other third parties

• Employers or unit commanders who can provide exposure records. The factors in s9 are expressed in cumulative hours and in timing relative to clinical onset/worsening, and thus any party in possession of employment records, job descriptions, attendance, or work histories will be implicated in establishing exposure thresholds. The instrument itself does not specify how such evidence must be obtained, but those data points are functionally material because the statutory factors are expressed in quantifiable time thresholds.

Entities referenced by cross‑linkage

• Administrators of other Statements of Principles. Section 11 brings other Statements into play where one of the s9 factors refers to an injury or disease covered by another Statement. Those other-SOP administrators indirectly affect claim outcomes when cross-referenced factors are invoked.

In short, the instrument principally affects claimants (veterans and their dependants), the RMA and administrative decision-makers under the VEA/MRCA, medical practitioners providing diagnostic and causal material, and any third parties holding records relevant to the quantifiable exposure and service connection predicates the instrument sets out.

The instrument does not create freestanding regulatory duties in the sense of imposing obligations on employers or regulators. Rather, it defines the factual predicates that must exist before a statutory "reasonable hypothesis" can be said to link asbestosis or death from asbestosis with relevant service. The key operative obligations and rights in the context of claims and assessments are therefore implicit; they concern what must be established or considered when a claim is assessed. Specific duties and rights that flow from the instrument’s provisions are as follows.

Duty to establish factors as a minimum

• Claimants must have at least one of the factors in s9 as a minimum to raise a reasonable hypothesis that their asbestosis, or death from it, is connected to relevant service. The instrument puts the onus, in functional terms, on the existence of those factors before connection to service can be plausibly asserted (s9 intro). The instrument does not itself allocate evidentiary burdens or procedural duties but defines the factual preconditions relevant to a causation finding.

Duty that factors be related to relevant service

• Any factor relied on under s9 must be related to the person’s relevant service (s10(1)). This means that even if a claimant can show exposure meeting one of the s9 thresholds, that exposure must be connected to the relevant service categories listed in Schedule 1 for the factor to operate in the causation calculus.

Differentiated application for aggravation/material contribution

• The factors in s9(3)-(4), which concern clinical worsening and inability to obtain appropriate clinical management, apply only to material contribution to, or aggravation of, asbestosis where the disease was suffered or contracted before or during but did not arise out of, the person's relevant service (s10(2)). This imposes a logical duty to determine chronological relations between onset/contracting, service and subsequent exposures or management failures.

Right to have other Statements applied when relevant

• If a factor in this instrument refers to an injury or disease that is covered by another Statement of Principles, the factors in that separate Statement apply as in force from time to time (s11). Claimants and decision-makers have the right to rely on, and the duty to consult, those other Statements where cross-references occur.

RMA’s declaratory function and evidentiary stance

• The instrument records the RMA’s view that sound medical‑scientific evidence indicates asbestosis can be related to relevant service (s8). This is a declaratory evidential stance the RMA presents as its basis for setting the factors. It does not convert the RMA into a tribunal hearing individual claims; rather it sets standards that adjudicators must apply.

Clinical diagnostic entitlement

• The instrument ties the legal meaning of asbestosis to the clinical definition in s7(2). A claimant has the right to have causation assessed against that clinical definition rather than an ICD code alone (s7(3)-(4)). Conversely, diagnostic codes by themselves will not displace the statutory definition.

Interaction duty for decision-makers

• Administrators must give effect to the Schedule’s definition of "relevant service" when applying the causation predicates (Schedule 1), and must interpret "death from asbestosis" in light of the Schedule’s definition of terminal events where mortality is alleged (s7(5); Schedule 1).

The instrument does not itself create investigatory powers, time limits, or procedural remedies. Those duties and rights are part of the broader VEA and MRCA schemes; this Statement provides the medical and exposure thresholds that feed into those statutory assessments. The practical effect is that parties (claimants and decision-makers) must engage with the s9 factors and the Schedule’s definitions when preparing or adjudicating claims. All of these points are grounded in the text: s9 sets the factors, s10 relates them to relevant service, s11 cross-links other Statements, s7 defines the disease and death concepts, and Schedule 1 defines key terms.

This Statement of Principles is a declaratory instrument made by the Repatriation Medical Authority under the VEA; it does not itself create civil or criminal penalties or an enforcement regime. The instrument’s enforcement and remedial consequences are mediated through the administrative and statutory machinery of the VEA and MRCA. The instrument’s text contains no express penalties, fines, or sanctions. The following points explain the instrument’s enforcement logic and role in claim determination.

No direct penal provisions in the instrument

• The instrument contains no provisions that impose penalties, sanctions, or criminal offences. It does not empower the RMA to impose fines or directions on third parties. It operates as a technical medical-causation standard in the statutory compensation context.

Administrative enforcement via VEA/MRCA decision-making

• The primary enforcement mechanism for the instrument’s effect is the VEA/MRCA decision process to which it applies (s5). Decision-makers under the VEA and MRCA use Statements of Principles to determine whether a "reasonable hypothesis" connects a condition to service. The outcome of applying the principles therefore affects entitlement to benefits, rehabilitation and compensation. While the instrument does not itself create those entitlements or sanctions, its role is consequential because it controls the causation predicates used in entitlement decisions.

Evidential consequence rather than penalty

• The instrument establishes factual thresholds (for example, cumulative hours of inhalation and latency) that must exist before a reasonable hypothesis is raised (s9). Failing to meet those factors will typically result in a negative causation finding in a claim assessment process and thus a denial of the claimed entitlement, which is the practical enforcement consequence. The instrument does not specify appeal pathways, but denial of an entitlement under the VEA/MRCA can trigger the administrative review and appeal mechanisms that those Acts provide. The instrument itself does not describe or modify those mechanisms.

No investigatory powers conferred

• The instrument does not confer investigatory powers on the RMA or other bodies. It is a statement of medical factors. Any investigations, document gathering, or use of enforcement powers to verify exposure will occur under other statutory authorities or administrative processes outside this instrument.

Interaction with other laws for enforcement

• The instrument instructs that where a factor refers to an injury or disease covered by another Statement of Principles, that other Statement applies in accordance with its terms (s11). Enforcement or application of those other Statements may carry relevant administrative consequences under the VEA/MRCA, but those are determined by the other instruments and the underlying legislation.

In short, enforcement is indirect and administrative: the Statement defines causation predicates that, when applied by the VEA/MRCA decision machinery, determine entitlement outcomes. The instrument itself contains no penal sections, fines, or powers to compel third parties beyond the role it plays in adjudicating claims under the overarching statutes.

The instrument is a component of the statutory framework established by the VEA and the MRCA. Its text explicitly identifies the statutes and other Statements of Principles with which it interacts and constrains. The interaction picture is compact and specified in the instrument itself.

Primary statutory interaction

• Veterans' Entitlements Act 1986. The Statement is made under subsection 196B(2) of the VEA (s3). It applies to claims to which section 120A of the VEA applies (s5). The VEA provides the statutory entitlement architecture within which the Statement’s factors operate; the Statement supplies the medical predicates for the "reasonable hypothesis" causation test used by decision-makers operating under the VEA. The instrument does not amend the VEA; it operates as an RMA determination made under its powers in that Act.
• Military Rehabilitation and Compensation Act 2004. The instrument explicitly applies to claims to which section 338 of the MRCA applies (s5). The MRCA’s decision framework for warlike and non-warlike service is therefore a parallel statutory context in which the Statement’s factors must be applied. The Schedule defines "relevant service" to include warlike and non‑warlike service under the MRCA (Schedule 1).

Interaction with other Statements of Principles

• Cross-reference mechanism. Section 11 provides that if a factor in this Statement refers to an injury or disease covered by another Statement determined under subsection 196B(2) of the VEA, then the factors in that other Statement apply according to their terms as in force from time to time. This creates a dynamic interaction: where asbestosis factors intersect with other conditions (for example, if a factor refers to exposure also relevant to another disease), the separate Statement’s rules govern that referred injury or disease. The instrument thereby defers to the existing regime of separate, condition-specific Statements in those circumstances.

Interaction with ICD classification

• The instrument notes that asbestosis attracts ICD‑10‑AM code J61 but makes clear that in applying the Statement the meaning of asbestosis is as given in s7(2) (s7(3)). It also defines which edition of ICD‑10‑AM is referenced (Tenth Edition, effective 1 July 2017) and cites the copyright owner (s7(4)). This limits the role of the ICD code to a classificatory note and makes the statutory textual definition controlling. Interaction with classification systems is therefore subordinated to the instrument’s explicit definition.

No modification of other statutory definitions outside Schedule 1

• The Schedule defines MRCA, VEA and relevant service categories for the purposes of this instrument (Schedule 1). The instrument does not purport to amend or displace those Acts’ definitions in any other context; it uses them to define the class of service for which the Statement’s factors are relevant.

Repeal and succession of Statements

• The instrument repeals the Statement of Principles concerning asbestosis No. 55 of 2013 (s4). That previous Statement is therefore superseded and replaced by the present instrument. Where claims were evaluated under the prior Statement, decision-makers now apply the new instrument once it has commenced (commencement is 21 June 2021, s2).

Limitations on extrinsic legal interactions

• The instrument does not address workers compensation, common law tort claims, industrial regulation or other non-VEA/MRCA compensation regimes. It is consequentially focused on the VEA/MRCA statutory scheme and other RMA Statements. Any interaction with other areas of law will depend on how courts or other statutory schemes treat these medical findings and the diagnostic definitions; the instrument itself contains no provisions about cross‑system application.

Overall, the instrument operates within the VEA/MRCA framework, cross-references other Statements of Principles where a factor invokes another condition, and clarifies that its clinical definition, not the ICD code alone, governs legal meaning in claims under these statutes.

The instrument itself provides a short, explicit amendment history limited to the replacement and timing of the current Statement. The relevant particulars recorded in the instrument are the following.

• Date of determination and seal. The Statement is dated 21 May 2021 and the instrument bears the Common Seal of the Repatriation Medical Authority affixed at the direction of the Chairperson, Professor Nicholas Saunders AO, as recorded on the instrument’s face (instrument header and signature page).
• Commencement. The instrument commences on 21 June 2021 (s2). That commencement date is the operative date for applying the new Statement to eligible claims under the VEA or MRCA.
• Repeal of prior Statement. The instrument expressly repeals the Statement of Principles concerning asbestosis No. 55 of 2013 (Federal Register of Legislation No. F2013L01643) made under subsection 196B(2) of the VEA (s4). The 2013 Statement is therefore no longer in force from the commencement date of this instrument.
• Authority for amendment. The instrument is made under subsection 196B(2) of the VEA (s3), which is the statutory power that enables the RMA to determine Statements of Principles and to update them over time. The instrument does not record prior amendment steps other than the repeal; it is presented as a replacement Statement.

No other amendments are listed in this instrument. There are no transitional provisions recorded in the text regarding claims in progress at the time of commencement. The instrument therefore takes effect on its commencement date and operates as the governing Statement of Principles for new and continuing claims under the sections of the VEA and MRCA to which it applies, subject to how decision-makers implement it procedurally under the parent statutes.

The instrument contains no litigation history. It does not cite any cases, judicial decisions, or tribunal determinations. The text does not record judicial consideration of its provisions, nor does it annex or rely upon court rulings. The only doctrinal statement in the instrument is the RMA’s declared view that there is sound medical‑scientific evidence indicating that asbestosis and death from asbestosis can be related to relevant service (s8). That is an administrative evidentiary assertion rather than a judicial holding.

Because the instrument is a Statement of Principles made by the RMA under subsection 196B(2) of the VEA, any litigation in which it is relevant would arise from disputes under the VEA or MRCA about whether a reasonable hypothesis has been raised in a particular claim. This instrument does not catalogue such litigation, and the text contains no references to matters decided by courts or tribunals. Consequently, for users seeking to understand judicial treatment of these factors, the instrument itself provides no litigation citations or summaries.

Practitioners should therefore note that the instrument functions as an administrative, RMA-determined Statement and that any litigation history relevant to its interpretation or application would need to be sought in the body of VEA and MRCA case law external to this Statement. The instrument does not supply that material nor imply judicial endorsement; it records only the RMA’s determination and the factors that decision-makers should apply when assessing reasonable hypothesis in claims within the VEA/MRCA framework.

The instrument is compact, but several technical features and potential pitfalls follow directly from its wording. These are matters that can materially affect how claims are prepared, argued and adjudicated. Each "gotcha" below cites the controlling provisions.

1. Legal meaning of asbestosis overrides ICD code

• Although the instrument notes that asbestosis attracts ICD‑10‑AM code J61, it explicitly states that the meaning of asbestosis for the purposes of this Statement is that given in s7(2): interstitial fibrosis of the lung caused by deposition of asbestos fibres in the lung parenchyma (s7(2)-(4)). The effect is that a recorded ICD code alone does not displace the statutory, clinical definition. Failure to address the s7(2) definition in clinical evidence risks the claim falling short of the instrument’s controlling meaning.

2. Quantitative cumulative-hour thresholds are literal minimums

• The s9 factors are expressed as cumulative hours and specific minimums: 1,000 hours in enclosed spaces (s9(1)(a)), 3,000 hours in open environments (s9(2)(a)), and 1,000 hours for exposure causing clinical worsening (s9(3)(a)). These are minimum predicates that the instrument declares must exist before a reasonable hypothesis is raised. The instrument itself sets those numeric thresholds and does not provide flexibility within the text for alternative measures of exposure.

3. Latency and timing thresholds matter

• For disease onset, the instrument requires that the first inhalation commenced at least 5 years before clinical onset (s9(1)(b) and s9(2)(b)). For worsening, exposures must be within 2 years before clinical worsening (s9(3)(b)). These time rules are concrete statutory criteria. Claimants and decision-makers must therefore align evidence on first inhalation and clinical onset/worsening dates to these thresholds.

4. Distinction between enclosed and open environments

• The instrument differentiates exposures occurring in enclosed spaces from those in open environments, applying a harsher cumulative-hours threshold to the latter (3,000 hours vs 1,000 hours) (s9(1)-(2)). The instrument provides a note that disturbance of debris or dust contaminated with asbestos fibres already present may result in exposure in either setting, but it does not define "enclosed space" or "open environment". This absence can create ambiguity in borderline cases where the setting could be characterised either way.

5. Clinical onset and clinical worsening terminology is consequential but not defined

• The instrument requires evidence of "clinical onset" and "clinical worsening" for timing purposes (s9). These terms are not separately defined in the instrument. That leaves those terms to be interpreted in practice by clinicians and decision-makers. The lack of statutory definitions can create disputes about when the clinical onset or worsening occurred for the purposes of meeting latency and timing thresholds.

6. Inability to obtain appropriate clinical management is a non‑exposure factor

• Section 9(4) lists "inability to obtain appropriate clinical management for asbestosis" as an alternative factor. The instrument does not define "appropriate clinical management" or set temporal or procedural parameters for how that inability is established. This potentially introduces an evidentiary and interpretive zone where decision-makers must assess whether management shortcomings materially affected the person’s condition.

7. Application to aggravation and material contribution is limited

• The factors in s9(3)-(4) apply only to material contribution to, or aggravation of, asbestosis where the disease was suffered or contracted before or during (but did not arise out of) relevant service (s10(2)). This is a narrowly framed rule that requires careful factual sequencing to determine whether the claim is for primary causation or for aggravation/material contribution.

8. Cross-referenced Statements may alter the analysis

• If a factor refers to another injury or disease covered by a different Statement of Principles, the rules of that Statement apply (s11). Practitioners must therefore identify any cross-references and ensure those other Statements are consulted as in force at the time.

9. Repeal effect and timing

• The instrument repeals the 2013 Statement (s4) and commenced on 21 June 2021 (s2). Claims lodged or assessed across the repeal/commencement boundary may raise issues about which Statement applies, and the instrument contains no transitional provisions. Decision-makers and advisers should be attentive to the operative date.

10. Narrow statutory scope

• The Statement applies only to claims under the specified sections of the VEA and MRCA (s5). It is not a general public health or workers compensation instrument and does not purport to regulate non-VEA/MRCA entitlements. Users must not assume it has application outside the specified statutory claims context.

Each of these points follows from the instrument’s wording. Practitioners should prepare claims with particular care in addressing the technical definitions (s7), the precise cumulative-hour and timing thresholds (s9), and the link to relevant service (s10 and Schedule 1).

Compliance in the context of this Statement of Principles means assembling the facts and medical material that satisfy the instrument’s minimum factors and related service requirements so that a decision-maker can find that a reasonable hypothesis has been raised connecting asbestosis or death from asbestosis to relevant service. The instrument itself prescribes what must exist (s9) and how those things must relate to service (s10). The following steps translate those textual requirements into concrete, source-grounded actions a claimant, representative or decision-maker will need to take.

1. Confirm the medical diagnosis against the statutory definition

• The starting point is the statutory definition in s7(2): asbestosis means interstitial fibrosis of the lung caused by deposition of asbestos fibres in the lung parenchyma. Ensure that the clinical evidence addresses that specific etiological and pathological formulation rather than relying solely on an ICD code. The instrument makes clear that this definition controls over the ICD code reference (s7(3)-(4)).

2. Identify whether the claim is for disease onset, clinical worsening, or death

• The factors in s9 distinguish between (a) exposures leading to clinical onset, (b) exposures causing clinical worsening, and (c) inability to obtain appropriate clinical management. Choose the correct factor stream: s9(1)-(2) are onset-related; s9(3) is worsening-related; s9(4) is management-related. If death is alleged, ensure evidence addresses whether death was from a terminal event contributed to by asbestosis (s7(5) and Schedule 1).

3. Establish relevant service

• The instrument applies to claims connected to "relevant service" as defined in Schedule 1. Identify whether the person’s service is within the VEA categories (operational, peacekeeping, hazardous, British nuclear test defence) or MRCA categories (warlike, non-warlike). Any factor relied upon under s9 must be related to that relevant service (s10(1)).

4. Map exposures to the s9 factor thresholds

• For onset factors, determine whether exposures occurred in an enclosed space or an open environment as that classification determines whether the cumulative threshold is 1,000 or 3,000 hours (s9(1)-(2)). Establish the cumulative duration of inhalation of respirable asbestos fibres and the date of first inhalation relative to clinical onset (s9(1)(a)-(b); s9(2)(a)-(b)). For worsening, establish cumulative hours in the two-year window prior to clinical worsening and confirm the 1,000-hour minimum (s9(3)(a)-(b)). The instrument’s notes recognise that disturbance of contaminated debris or dust in either setting may result in exposure; that factual reality should be reflected in the exposure narrative (s9 notes).

5. Demonstrate latency and timing

• For onset reliance, confirm that first inhalation commenced at least five years before clinical onset (s9(1)(b); s9(2)(b)). For worsening reliance, ensure exposures fall within the two years before worsening (s9(3)(b)). Document clinical onset/worsening dates in medical records linked to the diagnosis per s7.

6. If raising inability to obtain appropriate clinical management, document specifics

• The instrument permits inability to obtain appropriate clinical management as an alternative factor (s9(4)). Because the instrument does not define "appropriate clinical management", claims relying on this factor should set out the nature of the management sought, the specific inability experienced, and the timing relative to disease course so decision-makers can apply s10(2) where it concerns material contribution/aggravation.

7. Sequence onset/contracting, exposure and service

• If relying on s9(3)-(4) for aggravation/material contribution, confirm that asbestosis was suffered or contracted before or during the relevant service but did not arise out of it (s10(2)). This requires clear chronology in the evidence to show disease pre-existed or coincided with service in the specified way.

8. Consider cross-referenced Statements

• Where a factor refers to an injury or disease covered by another Statement, that other Statement’s factors apply (s11). Identify any cross-references and obtain and apply the text of the relevant separate Statement as in force.

9. Present medical opinion addressing statutory predicates

• Ensure that medical expert reports explicitly address the statutory predicates: the s7(2) definition, whether the clinical onset/worsening dates meet the s9 timing rules, whether cumulative inhalation meets the specified hours threshold, and whether exposures are connected to the relevant service as required by s10(1). If death is alleged, medical evidence should opine on whether the terminal event listed in Schedule 1 was contributed to by asbestosis (s7(5)).

10. Be explicit about setting and exposure mechanisms

• Because the instrument distinguishes enclosed space from open environment but does not define those terms, describe the workplace setting clearly (confined room, shipboard compartments, open-air construction site) and explain how work involved applying, removing, cutting, drilling, dislodging or disturbing asbestos-containing material, or disturbing contaminated debris or dust, as those are the exposure circumstances specified in s9.

11. Address potential gaps created by repeal/commencement

• The instrument repealed the 2013 Statement and commenced on 21 June 2021 (ss2-4). If a claim spans the repeal date, identify which Statement applies and be ready to explain how prior evidence maps to the new instrument’s thresholds.

12. Anticipate required linkage to relevant service categories

• Since the instrument explicitly ties factors to relevant service categories listed in the Schedule, ensure service records, deployment dates and roles are documented to show the exposure nexus to the category of service relied on.

All of the steps above are founded in the instrument’s precise text: the definition of asbestosis (s7), the factors and thresholds (s9), the relationship to service (s10) and the Schedule’s definitions. The instrument does not prescribe forensic methods or documentary sources; rather, it prescribes the factual predicates. Compliance therefore consists of assembling and presenting evidence that aligns to those textual predicates so that a reasonable hypothesis can be considered to have been raised within the VEA/MRCA decision framework.